Congratulations to Action Potential Venture Capital portfolio company, Neuspera Medical Inc. for receiving FDA PMA approval for their iSNM treatment of urge urinary incontinence. Stanford technology that APVC funded from the time of the Series A...this is a big day for this team, and for the many patients who've sat on the sidelines waiting for a better solution. #urinaryincontinence #overactivebladder #bioelectronicmedicines #sacralnervemodulation #electricityasmedicine
A new chapter for urinary urge incontinence (UUI) treatment begins. The FDA has approved Neuspera’s integrated sacral neuromodulation (iSNM) system, a smart, patient-centered alternative to traditional SNM therapies. Our iSNM system delivers proven UUI treatment to improve quality of life for the 1 in 5 U.S. women impacted by overactive bladder, often resulting in UUI. #Neuspera #UUI #MedicalInnovation #FDAApproval